Maravai LifeSciences Holdings (FRA:MAR) Interest Expense: €-22.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MAR Maravai LifeSciences Holdings Inc FRA:MAR
66 GF Score
Price €5.55
GF Value €3.33
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Interest Expense?

Maravai LifeSciences Holdings FRA:MAR +4.72% 66 Interest Expense is €-22.3 Mil as of Mar. 2026. GuruFocus rates FRA:MAR with a GF Score™ of 66/100 and a GF Value™ of €3.33 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Maravai LifeSciences Holdings's interest expense for the three months ended in Mar. 2026 was € -5.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-22.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Maravai LifeSciences Holdings's Operating Income for the three months ended in Mar. 2026 was € 0.6 Mil. Maravai LifeSciences Holdings's Interest Expense for the three months ended in Mar. 2026 was € -5.0 Mil. Maravai LifeSciences Holdings's Interest Coverage for the quarter that ended in Mar. 2026 was 0.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Maravai LifeSciences Holdings  (FRA:MAR) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Maravai LifeSciences Holdings's Interest Expense for the three months ended in Mar. 2026 was €-5.0 Mil. Its Operating Income for the three months ended in Mar. 2026 was €0.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €229.6 Mil.

Maravai LifeSciences Holdings's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*0.623/-4.973
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Maravai LifeSciences Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Interest Expense Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial -26.78 -19.27 -42.08 -45.55 -23.05

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.27 -5.91 -5.83 -5.60 -4.97
FRA:MAR
66GF Score
Maravai LifeSciences Holdings Inc FRA:MAR
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maravai LifeSciences Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-22.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-22.3 Mil mean?
Maravai LifeSciences Holdings (FRA:MAR) has a Interest Expense of €-22.3 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Maravai LifeSciences Holdings and its competitors.
Is Maravai LifeSciences Holdings' Interest Expense too high?
Maravai LifeSciences Holdings' current Interest Expense is €-22.3 Mil. Overall, Maravai LifeSciences Holdings has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Interest Expense compare to LBRX and SLDB?
Maravai LifeSciences Holdings' Interest Expense of €-22.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current Interest Expense is €-22.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings (FRA:MAR) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.33, compared to a current price of €5.55 — trading 66.7% above its estimated fair value. The current Interest Expense is €-22.3 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Maravai LifeSciences Holdings (FRA:MAR), the current Interest Expense is €-22.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (FRA:MAR) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of €5.55 is trading 66.7% above its estimated GF Value™ of €3.33. GuruFocus considers Maravai LifeSciences Holdings to be Significantly Overvalued.

Key valuation signals for FRA:MAR:

  • Interest Expense: €-22.3 Mil
  • GF Value™: €3.33 vs. price of €5.55 (66.7% above fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the FRA:MAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USA
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
66GF Score

Get the complete analysis for FRA:MAR

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€3.33
GF Value